Trial Profile
Intranasal CO2 for Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Carbon dioxide (Primary)
- Indications Allergic rhinitis; Grass pollen hypersensitivity; Ragweed pollen hypersensitivity
- Focus Therapeutic Use
- Sponsors Capnia
- 03 Feb 2016 New trial record